RANI THERAPEUTICS HOLDINGS, INC.
2051 Ringwood Avenue
San Jose, California 95131
December 27, 2022
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Rani Therapeutics Holdings, Inc.
Registration Statement on Form S-3
File No. 333-268855
Requested Date: December 29, 2022
Requested Time: 4:00 PM Eastern Time
Ladies and Gentlemen:
Rani Therapeutics Holdings, Inc. (the Registrant) hereby requests that the U.S. Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3, as amended to become effective on December 29, 2022, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Josh Seidenfeld of Cooley LLP, counsel to the Registrant, at (650) 843-5862, or in his absence, John T. McKenna at (650) 843-5059.
[Signature page follows]
|Very truly yours,|
|Rani Therapeutics Holdings, Inc.|
|By:||/s/ Eric Groen|
Josh Seidenfeld, Cooley LLP
John T. McKenna, Cooley LLP
[Signature Page to Acceleration Request]